Northwest Biotherapeutics Inc

Entity type image
Type: Company
Name: Northwest Biotherapeutics Inc
First reported 10 hours ago - Updated 9 hours ago - 2 reports

NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer

NORTHWEST BIOTHERAPEUTICS INC Symbol U : NWBO Recent Sedar Documents NW Bio Exhibit Will Describe DCVax Technology and Clinical Trial Progress at Annual Meeting of Over 25,000 Oncologists ... [Published Stockwatch - 10 hours ago]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Northwest Biotherapeutics, Inc. (NWBO) Begins Phase III Trial of DCVax-L for Brain Cancer

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products for the American and European markets to treat cancers more effectively than current treatments, while costing less, and without the toxicities associated ... [Published TransWorldNews - May 17 2013]
First reported May 16 2013 - Updated May 17 2013 - 2 reports

NW Bio Phase III trial with DCVax-L for brain cancer commences at King's College Hospital

Northwest Biotherapeutics (NW Bio) has announced that the King's College Hospital in the UK commenced Phase III trial with DCVax-L for brain cancer. ... [Published PBR - News - May 17 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials

Investment ThesisThis report is an update based on a number of recent events. I discuss encouraging long-term survival results for DC Vax-L that is unprecedented in glioblastoma multiforme. I also go over the phase III trial progress for DC Vax-L and ... [Published Seeking Alpha - May 08 2013]
Entities: Cancer, Patient, Phase III, Tumor
First reported May 08 2013 - Updated May 08 2013 - 1 reports
Apple Inc
Apple Inc

Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials

et dsdfs GOOG nflx SPY eeb ETF dia DRI efii DKK DVR EAT ETFPY dgp DELL DIS ETFC AXP AAPL ... [Published Zecco - May 08 2013]
First reported May 03 2013 - Updated May 04 2013 - 1 reports

Statement from Fix the Debt Small Business Leaders

/PRNewswire-USNewswire/ -- "On Friday, the federal government released the April jobs report. Private-sector employers added 176,000 jobs in April, of which more than 40 percent were created by small businesses, according to initial estimates."While this ... [Published NewsBlaze - May 03 2013]
First reported May 03 2013 - Updated May 04 2013 - 6 reports

Interviews Of Northwest Bio's CEO Linda Powers, On The Floor Of The New York Stock Exchange

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced the availability on the web of several interviews of their CEO Linda Powers on the floor of the ... [Published Citybizlist - May 04 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Online Solar School Campaign Raising Funds to Spread Solar Knowledge for People Power

/PRNewswire-iReach/ -- Energy. Sustainability. Community. Through a partnership between these elements, we can create the future we hope for. Human nature is to observe, learn and then make change. This is an inevitable process. With the power of modern ... [Published NewsBlaze - May 03 2013]
First reported May 01 2013 - Updated May 01 2013 - 1 reports

With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse

There's a man in my neighborhood that has ALS. Diagnosed 2 years ago, he can no longer move his arms or keep his head up. He can still walk and talk, but he and everyone in our neighborhood knows that the clock is ticking. Recently I naively went up to ... [Published Seeking Alpha - May 01 2013]
First reported Apr 18 2013 - Updated Apr 19 2013 - 9 reports

Another Brain Cancer Patient Surpasses 10-Year-Cancer-Free Survival

NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free SurvivalUnprecedented Results Compared With Current Standard of Care BETHESDA, Md., April 18, 2013 /PRNewswire/ -- Northwest Biotherapeutics ... [Published Pharma Live - Apr 18 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 2 reports

NW Biotherapeutics, Inc. (NWBO) Announces Adoption o...

Northwest Biotherapeutics yesterday announced its Phase III clinical trial for Glioblastoma multiforme (GBM) brain cancer has been adopted as a national priority trial in the United Kingdom under the adoption program managed by the National Institute ... [Published StockHouse USA - Apr 17 2013]
First reported Apr 16 2013 - Updated Apr 16 2013 - 5 reports

Northwest Biotherapeutics (NWBT)'s Phase III Trial With DCVax-L for Brain Cancer "Adopted" as a National Priority Trial in UK

/PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the Company's Phase III clinical trial for Glioblastoma multiforme ... [Published BioSpace - Apr 16 2013]

Quotes

...about our broad DCVax technology for personalized immune therapy treatments for all solid tumor cancers," commented Linda Powers, NW Bio CEO. "Immune therapies have become an area of rapidly growing interest among oncologists, and NW Bio is strongly positioned at the forefront of this emerging new treatment category, with two product lines already at the Phase III clinical trial stage and a third product line at the Phase I II trial stage. We look forward to raising awareness of our DCVax technology and products with a major exhibit at this year's ASCO meeting."
NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy fo ... [Published Zecco - 10 hours ago]
...ollaboration with the company to include another aspect of our technology platform," said Lawson Macartney, Ph D , chief executive officer of Ambrx. "We look forward to working together to further utilize Ambrx's technology to discover and advance these antibody drug conjugates for oncology indications."
Ambrx and Bristol-Myers Squibb Collaborate on Discovery; Bristol-Myers Squibb Receives US FDA sND ... [Published BioMedReports - May 04 2013]
"Announcing a plan to shrink the deficit and put the debt on a downward trajectory as a share of the economy would provide greater confidence to our nation's small businesses, and, as a result, provide the assurance essential for businesses to make the investments that allow for success. Most importantly it would spur an increase in opportunities for small businesses to hire more workers and contribute to a stronger economy. We stand with the Campaign to Fix the Debt in its efforts to let our elected leaders know that inaction is no longer an option. For the sake of America's small businessmen and -women, it's time to fix the debt."
Statement from Fix the Debt Small Business Leaders [Published NewsBlaze - May 03 2013]
...my wife several months pregnant, I was determined to find a clinical trial that would allow me to see and raise my son," commented Brad Silver . "When that quest led me to DCVax and Dr. Linda Liau at UCLA, the natural renewal of my own immune system made more sense to me than just a continuation of the system-wide poisoning of chemotherapy. And it worked. Not only did the tumor disappear and stay away for all this time, but the only side effect I had was unbridled happiness and a new freedom. My son Brad II, who was born 10 days after my first DCVax treatment, will be 10 years old next week, and today I am there for my family thanks to DCVax."
GBM brain cancer patient treated with DCVax-L celebrates 10th anniversary of cancer-free survival [Published News-Medical.Net - Apr 19 2013]

More Content

All (116) | News (75) | Reports (10) | Blogs (10) | Audio/Video (1) | Fact Sheets (0) | Press Releases (20)
sort by: Date | Relevance
NWBO: Great Progress Made to Advance DCVax-L an... [Published Yahoo! Finance - 9 hours ago]
NW Bio Exhibit at the Upcoming ASCO Meeting to ... [Published Stockwatch - 10 hours ago]
NW Bio Exhibit at the Upcoming ASCO Meeting to ... [Published Zecco - 10 hours ago]
NW Bio Exhibit at the Upcoming ASCO Meeting to ... [Published PR Newswire: Health - 10 hours ago]
250 vaccines in development, including these Ph... [Published Terrapinn - May 20 2013]
Northwest Biotherapeutics, Inc. (NWBO) - Medica... [Published TransWorldNews - May 19 2013]
Northwest Biotherapeutics, Inc. (NWBO) Begins P... [Published TransWorldNews - May 17 2013]
NW Bio Phase III trial with DCVax-L for brain c... [Published PBR - News - May 17 2013]
NW Bio starts Phase III clinical trial with DCV... [Published News-Medical.Net - May 17 2013]
Northwest Biotherapeutics, Inc. (NWBO) Begins P... [Published StockHouse USA - May 16 2013]
NW Bio Initiates Phase III DCVax®-L Brain Cance... [Published PR Newswire: Health - May 16 2013]
SmithOnStocks Opines On Recent Biotech News [Published Seeking Alpha - May 13 2013]
Area CEOs cash in on stock as workers see drop ... [Published Gazette.net - May 10 2013]
Northwest Biotherapeutics: Moving DC Vax-L Rapi... [Published Seeking Alpha - May 08 2013]
Northwest Biotherapeutics: Moving DC Vax-L Rapi... [Published Zecco - May 08 2013]
Mentor Capital Reports First Quarter Results fo... [Published Individual.com - May 07 2013]
Ambrx and Bristol-Myers Squibb Collaborate on D... [Published BioMedReports - May 04 2013]
Interviews Of Northwest Bio's CEO Linda Powers,... [Published Citybizlist - May 04 2013]
Interviews Of NW Bios CEO, On The Floor Of The ... [Published Street Insider - May 03 2013]
Statement from Fix the Debt Small Business Leaders [Published NewsBlaze - May 03 2013]
Patient Services, Inc. Honors Members of Congre... [Published NewsBlaze - May 03 2013]
Interviews Of NW Bio's CEO, On The Floor Of The... [Published NewsBlaze - May 03 2013]
Interviews Of NW Bio's CEO, On The Floor Of The... [Published Stockwatch - May 03 2013]
Online Solar School Campaign Raising Funds to S... [Published NewsBlaze - May 03 2013]
Interviews Of NW Bio's CEO, On The Floor Of The... [Published TickerTech.com - May 03 2013]
Interviews Of NW Bio's CEO, On The Floor Of The... [Published PR Newswire: Health - May 03 2013]
Financing of the Fortnight Wonders If It's Time... [Published The IN VIVO Blog - May 03 2013]
Mentor Capital Cancer Immunotherapy Index Gains... [Published NewsBlaze - May 02 2013]
Latest Advances in Cancer Research [Published FOX Business - Video - May 01 2013]
With A New Institutional Investor On Board, Nor... [Published Seeking Alpha - May 01 2013]
1 2 3 4
In Focus
  •  
Linda Powers, LARRY SMITH, Ron Paul, [more]
  •  
Nasdaq Stock Market Inc, New York Stock Exchange, Dendreon Corp, [more]
  •  
US Securities and Exchange Commission, University of Pennsylvania, UCLA, [more]
  •  
8-k, Brain Cancer, Phase III, [more]
  •  
Xtandi, Zytiga, Surfaxin, [more]
  •  
Washington DC, Vancouver, Chicago, [more]
  •  
United Kingdom, United States, Germany, [more]
  •  
Diseases, Epidemics, Medication, [more]
  •  
IT, Telecom, Banking & Financial Services, [more]
SEC Filings, Healthcare Sector and Stocks Analysis from Seek..., PR Newswire: Health, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
NW Bio Phase III trial with DCVax-L for brain c... [Published PBR - News - May 17 2013]
Northwest Biotherapeutics (NW Bio) has announced that the King's College Hospital in the UK commenced Phase III trial with DCVax-L for brain cancer. ...
Financing of the Fortnight Wonders If It's Time... [Published The IN VIVO Blog - May 03 2013]
Biotech workers of the world unite, you have nothing to exercise but your stock options. At least a few more do these days. We’re far from the cries of “Mayday!” that echoed from the bottom of the financial canyon four years ago, and as we write this, ...
4 Healthcare Stock Stories For Tuesday Investme... [Published Wall St. Cheat Sheet - Apr 16 2013]
Biogen IDEC ( NASDAQ: BIIB ): Current price $201.70 The United States Court of Appeals for the Federal Circuit in Washington has ruled against an appeal made by Biogen and Roche’s Genetech in a patent infringement case against GlaxoSmithKline ...
Is Dendreon Undervalued? [Published Wall St. Cheat Sheet - Apr 15 2013]
With shares of  Dendreon  ( NASDAQ:DNDN )   trading around $4, is DNDN an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our  CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Dendreon is ...
Pressure BioSciences deeply undervalued, says a... [Published Proactiveinvestors United Kingdom website - Apr 05 2013]
Shares of  Pressure BioSciences  ( OTCQB:PBIO ), a life sciences company focused on developing its pressure cycling technology (PCT), have been described as "deeply undervalued", according to Zacks Investment Research analyst Grant Zeng, when looking ...
1 2

Audio/Video

sort by: Date | Relevance
Latest Advances in Cancer Research [Published FOX Business - Video - May 01 2013]
1

Press Releases

sort by: Date | Relevance
NW Bio Exhibit at the Upcoming ASCO Meeting to ... [Published PR Newswire: Health - 10 hours ago]
NW Bio Initiates Phase III DCVax®-L Brain Cance... [Published PR Newswire: Health - May 16 2013]
Interviews Of NW Bio's CEO, On The Floor Of The... [Published PR Newswire: Health - May 03 2013]
NW Bio Announces That Another Brain Cancer Pati... [Published PR Newswire: Health - Apr 18 2013]
NW Bio Announces $10 Million Registered Direct ... [Published Financial Services - Apr 18 2013]
1 2 3 4
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.